Viewing Study NCT00069992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-01-28 @ 6:28 AM
Study NCT ID: NCT00069992
Status: TERMINATED
Last Update Posted: 2012-10-10
First Post: 2003-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
Sponsor: Baylor College of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None polycythemia vera View
None essential thrombocythemia View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None primary myelofibrosis View
None chronic myelogenous leukemia View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None childhood myelodysplastic syndromes View